Answers are grounded in this paper and cite their sources.
The shelf life of pharmaceutical products depends on the stability of active pharmaceutical ingredients in the presence of other formulation components and environmental factors. Degradation processes can be suppressed by the addition of protective excipients. The present work is concerned with understanding the role of spatial arrangement of drug and protectant particles at the tablet microstructure level on the effectiveness of protection against pH induced degradation. Atorvastatin – a major cardiovascular drug – was chosen as a case to investigate the possibility to suppress lactone impurity formation by modifying the tablet pH microenvironment. The effect of the quantity added, particle size, and process route on the protective effect of Na 2 CO 3 as a protective agent has been systematically investigated by accelerated stress tests under 30% and 75% relative humidity at 60 °C. The addition of Na 2 CO 3 into the tablet formulation in the range from 2.5 to 20.0 wt.% relative to atorvastatin was found to be effective in suppressing degradation but the efficacy was strongly dependent on the process route and the particle size. The direct compression route was found to be equally or more effective than wet granulation. Scanning electron microscopy analysis with elemental mapping revealed that the use of fine Na 2 CO 3 particles resulted in a uniform mixing with atorvastatin particles, whereas coarse particles were too few and far between to provide effective pH protection. Based on these results, a general framework for determining the appropriate particle size, quantity and route of addition of protective excipients into pharmaceutical tablet formulations has been proposed.
No takes yet. Share an insight, caveat, or question.
Hlavačková et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: